Viadana, 17th November 2026 – Today Numantec (the “Company”), a leading developer, manufacturer and distributor of infusion medical devices, announced that Private Equity at Goldman Sachs Alternatives has completed its acquisition of the Company from White Bridge Investments and other existing shareholders.
With Goldman Sachs Alternatives as its key partner, Numantec will focus on accelerating its next stage of growth. This includes scaling its existing footprint and product portfolio, expanding into new geographies and channels, and acquiring and developing new products. Building on its record of organic growth and successful acquisitions, the Company is well positioned to benefit from structural trends shaping the global medical consumables market and to continue delivering innovative solutions that improve patient care and safety.
Gabriele Giovanelli, Numantec CEO, said: “Completing this transaction marks an exciting new chapter for Numantec. We are proud of the growth we have achieved and are delighted to welcome Goldman Sachs Alternatives as our new partner. Together with our approximately 600 colleagues I look forward to the next phase of our journey, and growing our geographic footprint, broadening our product portfolio, and continuing serving patients across homecare and hospital settings worldwide.”
About Numantec
Numantec is a leading developer, manufacturer and distributor of infusion medical devices. Its comprehensive portfolio of innovative solutions is designed to enhance patient care and safety. The Company serves the full infusion care pathway, from vascular access devices and injection systems to elastomeric and electronic pumps and pre-filled syringes. Headquartered in Viadana, Italy, Numantec has a direct presence in Italy, France, Germany and the United States. It employs approximately 600 people and operates seven state-of-the-art manufacturing facilities across Europe and the United States.
For further information, please visit https://numantecgroup.com
About Private Equity at Goldman Sachs Alternatives
Goldman Sachs (NYSE: GS) is one of the leading investors in alternatives globally, with over $706 billion in assets and more than 30 years of experience. The business invests in the full spectrum of alternatives including private equity, growth equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Clients access these solutions through direct strategies, customized partnerships, and open-architecture programs.
The business is driven by a focus on partnership and shared success with its clients, seeking to deliver long-term investment performance drawing on its global network and deep expertise across industries and markets.
The alternative investments platform is part of Goldman Sachs Asset Management, which delivers investment and advisory services across public and private markets for the world’s leading institutions, financial advisors and individuals. Goldman Sachs has approximately $4.1 trillion in assets under supervision globally as of September 30, 2026.
Established in 1986, Private Equity at Goldman Sachs Alternatives has invested over $89 billion since inception. The business combines a global network of relationships, unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across its portfolios.






